Atrial Fibrillation

       　心房颤动简称房颤,是一种十分常见的心律失常。据统计，60岁以下的患病率为1％，并随年龄而增加。房颤的发作呈阵发性或持续性。房颤时，心房内激动传导的方向不一致，频率快而且不规整，这使心房丧失了有效的收缩功能。房颤时心房的激动频率高达300～600次/分，虽然由于房室结的保护作用可使这些激动不能全部到达心室，但是心室率（心率）仍然可达到100～160次/分，不仅比正常窦性心律快得多，而且节律绝对不整齐。为此，CMBI特搜集了关于Atrial Fibrillation的相关文献，供大家参考。更多的资料 ,请用相关关键词通过CMBI文献查询获取。

• Pulmonary Vein Total Occlusion Following Catheter Ablation for Atrial Fibrillation
  
• DC cardioversion of persistent atrial fibrillation
  
• Atrial strain rate echocardiography can predict success or failure of cardioversion for atrial fibrillation
  
• A Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Paroxysmal Atrial Fibrillation
  
• Previously known and newly diagnosed atrial fibrillation
  
• Doppler echocardiographic prediction of recurrent atrial fibrillation following cardioversion
  
• Preoperative atrial histological changes are not associated with postoperative atrial fibrillation
  
• Perceived Effects on Patients' Health of Participation in the Atrial Fibrillation Follow-up Investigation of Rhythm Management Study
  
• Long-term outcome after cardioversion of atrial fibrillation
  
• Internal Cardioversion Shortens Periods of Postoperative Atrial Fibrillation
  
• Verapamil Versus Digoxin and Acute Versus Routine Serial Cardioversion for the Improvement of Rhythm Control for Persistent Atrial Fibrillation
  
• Selective Atrial Vagal Denervation Guided by Evoked Vagal Reflex to Treat Patients With Paroxysmal Atrial Fibrillation
  
• Risk of Thromboembolic Events After Percutaneous Left Atrial Radiofrequency Ablation of Atrial Fibrillation
  
• Molecular Determinants of Altered Ca2+ Handling in Human Chronic Atrial Fibrillation
  
• Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation
  
• Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate
  
• Additive Role of Plasma von Willebrand Factor Levels to Clinical Factors for Risk Stratification of Patients With Atrial Fibrillation
  
• Quality of Life and Exercise Performance in Patients in Sinus Rhythm Versus Persistent Atrial Fibrillation
  
• Predictors of non-pharmacological intervention in patients with paroxysmal atrial fibrillation
  
• Atrial fibrillation in dobutamine stress echocardiography
  
• Pharmacologic approaches to rhythm versus rate control in atrial fibrillation—where are we now
  
• Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy
  
• Fibrinogen and Albumin Levels and Risk of Atrial Fibrillation in Men and Women (the Copenhagen City Heart Study)
  
• Effects of Two Different Catheter Ablation Techniques on Spectral Characteristics of Atrial Fibrillation
  
• Determinants of Thoracic Electrical Impedance in External Electrical Cardioversion of Atrial Fibrillation
  
• Atrial fibrillation in patients hospitalized for congestive heart failure
  
• Usefulness of Paroxetine in Depressed Men With Paroxysmal Atrial Fibrillation
  
• Somatic Mutations in the Connexin 40 Gene (GJA5) in Atrial Fibrillation
  
• Plasma Atrial Natriuretic Peptide and Brain Natriuretic Peptide Levels After Radiofrequency Catheter Ablation of Atrial Fibrillation
  
• Phrenic Nerve Injury After Atrial Fibrillation Catheter Ablation
  
• Left Atrial Ablation Versus Biatrial Ablation for Persistent and Permanent Atrial Fibrillation
  
• Cost-Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
  
• Sites of Focal Atrial Activity Characterized by Endocardial Mapping During Atrial Fibrillation
  
• Significance of recurrences of new atrial fibrillation in acute myocardial infarction
  
• Quality of Life in Patients with Atrial Fibrillation
  
• Molecular genetics-Cardiac connexins as candidate genes for idiopathic atrial fibrillation
  
• Mechanisms of Disease genetic mechanisms of atrial fibrillation
  
• Effects of a Na+-Ca2+ exchanger inhibitor on pulmonary vein electrical activity and ouabain-induced arrhythmogenicity
  
• Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial Fibrillation
  
• Translating the Results of Randomized Trials into Clinical Practice
  
• Robotic Magnetic Navigation for Atrial Fibrillation Ablation
  
• Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation
  
• Frequency Analysis in Different Types of Paroxysmal Atrial Fibrillation
  
• Drug Insight angiotensin-converting-enzyme inhibitors and atrial fibrillation—indications and contraindications
  
• D-dimer level influences thromboembolic events in patients with atrial fibrillation
  
• Cardiac resynchronisation therapy in chronic atrial fibrillation
  
• A Tailored Approach to Catheter Ablation of Paroxysmal Atrial Fibrillation
  
• A comparison of low versus high heart rate in patients with atrial fibrillation and advanced chronic heart failure
  
• Sport practice and the risk of lone atrial fibrillation
  
• Spectral turbulence analysis of the signal-averaged electrocardiogram of the atrial activation as predictor of recurrence of idiopathic and persistent atrial fibrillation
  
• Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation
  
• Optimal INR for prevention of stroke and death in atrial fibrillation
  
• Electrical cardioversion for persistent or chronic atrial fibrillation
  
• Circumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation
  
• Chronic Atrial Dilation, Electrical Remodeling, and Atrial Fibrillation in the Goat
  
• C-reactive protein and atrial fibrillation
  
• Assessment of left ventricular systolic function in patients with chronic atrial fibrillation and dilated cardiomyopathy using the ratio of preceding to prepreceding R–R intervals
  
• Ambulatory electrical cardioversion of atrial fibrillation
  
• Short-term Exercise Training in Patients With Chronic Atrial Fibrillation
  
• Selective Induction of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Atrial and Ventricular Myocardium in Patients With Atrial Fibrillation
  
• Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO System) to Prevent Stroke in High-Risk Patients With Non-Rheumatic Atrial Fibrillation
  
• Patterns and Predictors of Warfarin Use in Patients With New-Onset Atrial Fibrillation from the FRACTAL Registry
  
• Mechanisms of Wave Fractionation at Boundaries of High-Frequency Excitation in the Posterior Left Atrium of the Isolated Sheep Heart During Atrial Fibrillation
  
• Impact of adverse events on prescribing warfarin in patients with atrial fibrillation
  
• Controversies in atrial fibrillation
  
• Anatomic substrate, procedural results, and clinical outcome of ultrasound-guided left atrial pulmonary vein disconnection for treatment of atrial fibrillation
  
• Acute Pyloric Spasm and Gastric Hypomotility
  
• Meta-analysis of clinical outcomes of maze-related surgical procedures for medically refractory atrial fibrillation
  
• Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man
  
• Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin
  
• Antithrombotic treatment in atrial fibrillation